DAPHNE HARRIS: Open Payments
NPI 1205175023 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 7 payments from 7 companies in 2025. Trend: 2023 $157 · 2024 $466 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $183 |
| Amgen Inc. | 1 | $146 |
| EVOKE PHARMA, INC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $113 |
| Novo Nordisk Inc | 1 | $108 |
| Astellas Pharma US Inc | 1 | $25 |
| ABBVIE INC. | 1 | $22 |
Products named: FREESTYLE LIBRE 3, GIMOTI, BREZTRI, Ozempic, Veozah, UBRELVY.
Industry payments across TN — which companies pay providers there.
